Ljubljana, Slovenia

Roman Jerala

This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Kemijski Institut, Osterreichische Akademie Der Wissenschaften. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roman Jerala. Retrieved from https://idiyas.com/inventor/roman-jerala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roman Jerala: Innovator in Immunotherapy and Antimicrobial Research

Introduction

Roman Jerala is a prominent inventor based in Ljubljana, Slovenia. He has made significant contributions to the fields of cancer immunology and antimicrobial research. With a total of 2 patents, his work focuses on innovative solutions that address critical health challenges.

Latest Patents

Jerala's latest patents include groundbreaking inventions in immunotherapy. One of his notable patents is related to split superantigens and their use for immunotherapy. This invention refers to a split superantigen that is divided into two fragments, which by themselves do not exhibit biological activity. Only upon dimerization do they regain T cell activity. The scope of this invention includes a screening method for detecting effective split superantigen designs, where the fragments are fused with coiled-coil forming peptides. This invention is particularly relevant in the field of cancer immunology, as it allows for the activation of T-cell responses when the split superantigen-antibody fusion proteins bind to tumor antigens.

Another significant patent involves antimicrobial peptides. This invention relates to families of polypeptides and lipopolypeptides that possess antimicrobial and endotoxin-neutralizing activities. These molecules demonstrate a broad spectrum of activity against various pathogens, including bacteria, viruses, and fungi. The compounds can be utilized alone or in combination therapy with conventional antibiotics or antiendotoxic agents. Additionally, the invention discloses processes for making and using these compounds.

Career Highlights

Throughout his career, Jerala has worked with esteemed institutions such as the Austrian Academy of Sciences and the Chemical Institute. His research has significantly advanced the understanding and application of immunotherapy and antimicrobial treatments.

Collaborations

Jerala has collaborated with notable individuals in his field, including Sylvie E Blondelle and Primoz Pristovsek. These collaborations have further enriched his research and contributed to the development of innovative solutions in health sciences.

Conclusion

Roman Jerala is a distinguished inventor whose work in immunotherapy and antimicrobial research has the potential to transform medical treatments. His innovative patents reflect a commitment to addressing critical health issues through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…